Cardiotoxicity of Abiraterone and Enz... - Advanced Prostate...

Advanced Prostate Cancer

21,849 members27,365 posts

Cardiotoxicity of Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

pjoshea13 profile image
8 Replies

I don't recall this being posted:

"... the abiraterone acetate group was at greater risk of cardiovascular-related hospitalization compared to the enzalutamide group (hazard ratio (HR) 1.82 ...).

"Further, the risk of hospitalization for heart failure was greater in abiraterone acetate (HR 2.88 ...)."

urotoday.com/conference-hig...

-Patrick

Written by
pjoshea13 profile image
pjoshea13
To view profiles and participate in discussions please or .
Read more about...
8 Replies
cesces profile image
cesces

Is the suspect mechanism the simple lowering of testosterone?

Or do they think it is more complicated or nuanced.

pjoshea13 profile image
pjoshea13 in reply to cesces

Recognize that the development of Abi was a scorched earth attack on all hormones in the steroidogenesis cascade south of pregnenolone & progesterone:

en.wikipedia.org/wiki/Stero...

So, what might be the effect of removing dehydroepiandrosterone [DHEA], say, from the body? It is super-abundant normally, although there is a considerable reduction with age.

"Dehydroepiandrosterone and its sulfate predict the 5-year risk of coronary heart disease events in elderly men" [2014, Sweden]

"Low serum levels of DHEA and its sulfate predict an increased risk of {coronary heart disease} ..."

pubmed.ncbi.nlm.nih.gov/254...

I chose DHEA at random. One could investigate the other hormones as to their importance to cardio health.

Enza targets the AR, rather than its ligands & perhaps thats the reason

-Patrick

Nous profile image
Nous

thanks for sharing this Patrick ... best wishes ... Nous :)

tango65 profile image
tango65

It seems the difference is due to a higher incidence of heart failure in the group taking abiraterone.

This is not surprising since abiraterone can cause a mineralocorticosteroid syndrome due to increase in aldosterone which leads to water retention, edema , hypertension and hypokalemia.

This situation could decompensate the heart function of people already having a reduction of the heart ejection fraction.

All the other cardiovascular complications are not significant different between abiraterone and enzalutamide.

LearnAll profile image
LearnAll in reply to tango65

Tango..I agree what you are saying....Abiraterone has common side effect of raising Blood Pressure and high blood pressure for a long time leads to left ventricular hypertrophy eventualy culminating in congestive heart failure. Other than CHF, both drugs are eually cardiotoxic.

But if Blood pressure is well controlled with proper plant based diet, low sodium, ideal body weight and BP lowering medicines, the extra risk of heart failure can be greatly reduced.

tango65 profile image
tango65 in reply to LearnAll

I think the main problem may be volume overload (caused by the water and Na retention) in a patient with borderline systolic heart failure. Further dilatation of the ventricles could lead to worse systolic insufficiency or heart failure.

Hypertension and ventricular hypertrophy of the left ventricle will lead to diastolic insufficiency, but this take time, several years with significant hypertension.

LearnAll profile image
LearnAll in reply to tango65

Exactly.....Congestive heart failure is a chronic process and takes 10 to 20 years to reach to life threatening level ...when the ejection fraction falls below 20. At terminal stage, the heart looks like "boot shaped" on X ray. Clinically it manifests as severe shortness of breath, inability to walk even 100 feet without getting short of breath.Sodium rich processed foods make it worse whereas pottassium rich fruits and vegetables slow the process of heart failure.In our cooking, we do not use regular salt because it is 100% sodium chloride. We use

"low salt" or "50/50 salt" which has 50% Sodium chloride and 50% Potassium Chloride. Keeping blood pressure equal to or less than 130/90 ertainly delays heart failure.

kainasar profile image
kainasar

This report may be useful.

Pharmacokinetic Interactions Between Abiraterone, Apalutamide, Darolutamide or Enzalutamide and Antithrombotic Drugs: Prediction of Clinical Events and Review of Pharmacological Information

pubmed.ncbi.nlm.nih.gov/371...

Not what you're looking for?

You may also like...

Abiraterone in Metastatic Hormone-Sensitive Prostate Cancer

TAKE-HOME MESSAGE •This is a post-hoc analysis of the STAMPEDE study, where the outcomes of...

Abiraterone and Enzalutamide Raise Metabolic, Cardiovascular Adverse Event Risks

Abiraterone was significantly associated with an 84% and 37% increased risk for a major or minor...

Abiraterone Acetate Plus Prednisone in Newly Diagnosed High-Risk Metastatic Castration-Sensitive Prostate Cancer: Final OS Results

TAKE-HOME MESSAGE •The authors report long-term survival outcomes among patients with newly...

Olaparib for Metastatic Castration-Resistant Prostate Cancer

TAKE-HOME MESSAGE •In this phase III study, 387 patients with metastatic castration-resistant...

Abiraterone Acetate Plus Prednisone in Newly Diagnosed High-Risk Metastatic Castration-Sensitive Prostate Cancer

The Lancet Oncology TAKE-HOME MESSAGE...